| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 116.59B | 115.59B | 108.28B | 103.61B | 93.74B | 81.37B |
| Gross Profit | 33.63B | 32.79B | 31.03B | 29.42B | 27.66B | 24.85B |
| EBITDA | 10.04B | 8.25B | 13.15B | 13.07B | 8.40B | 11.20B |
| Net Income | 3.02B | 1.50B | 6.18B | 5.72B | 1.21B | 3.94B |
Balance Sheet | ||||||
| Total Assets | 119.90B | 120.69B | 125.62B | 118.97B | 116.38B | 116.28B |
| Cash, Cash Equivalents and Short-Term Investments | 17.02B | 17.71B | 17.93B | 17.96B | 19.57B | 19.30B |
| Total Debt | 2.04B | 7.14B | 7.59B | 11.57B | 13.83B | 20.00B |
| Total Liabilities | 33.76B | 38.19B | 40.11B | 40.96B | 43.95B | 45.52B |
| Stockholders Equity | 85.89B | 82.13B | 85.16B | 77.66B | 72.13B | 70.49B |
Cash Flow | ||||||
| Free Cash Flow | 9.30B | 6.50B | 9.69B | 3.99B | 5.99B | 6.27B |
| Operating Cash Flow | 13.50B | 10.76B | 14.06B | 7.71B | 9.59B | 10.17B |
| Investing Cash Flow | -2.79B | -4.19B | -4.74B | -3.98B | -534.00M | -2.77B |
| Financing Cash Flow | -11.06B | -6.91B | -8.96B | -6.43B | -9.94B | -3.63B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | ¥109.93B | 16.52 | ― | 4.64% | 3.99% | -28.28% | |
78 Outperform | ¥128.52B | 12.30 | ― | 2.25% | 12.64% | 34.19% | |
71 Outperform | ¥87.55B | 28.82 | ― | 3.82% | 3.68% | -46.19% | |
69 Neutral | ¥144.91B | 19.89 | ― | 3.88% | 1.70% | 18.50% | |
68 Neutral | ¥92.93B | 12.55 | ― | 3.24% | 18.70% | 33.93% | |
67 Neutral | ¥124.84B | 15.37 | ― | 2.50% | -2.46% | -10.72% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% |
Bando Chemical Industries Ltd. has completed the acquisition of its own shares, purchasing a total of 25,300 shares for 51,560,199 yen between December 1 and December 2, 2025. This acquisition is part of a larger plan approved by the Board of Directors to acquire up to 1,800,000 shares, with a maximum budget of 2 billion yen, aimed at enhancing shareholder value and optimizing capital structure.
The most recent analyst rating on (JP:5195) stock is a Hold with a Yen2096.00 price target. To see the full list of analyst forecasts on Bando Chemical Industries Ltd. stock, see the JP:5195 Stock Forecast page.
Bando Chemical Industries, Ltd. announced the acquisition of its own shares, acquiring 203,200 shares at a cost of 399,889,495 yen during November 2025. This move is part of a broader strategy approved by the Board of Directors to acquire up to 1,800,000 shares by April 2026, enhancing shareholder value and optimizing capital structure.
The most recent analyst rating on (JP:5195) stock is a Hold with a Yen2096.00 price target. To see the full list of analyst forecasts on Bando Chemical Industries Ltd. stock, see the JP:5195 Stock Forecast page.
Bando Chemical Industries, Ltd. has revised its consolidated financial forecast for the fiscal year ending March 31, 2026, increasing revenue and profit expectations due to favorable exchange rate assumptions and insurance claim income. Despite rising costs, the company anticipates higher operating profits, reflecting steady growth and strategic financial management.
The most recent analyst rating on (JP:5195) stock is a Hold with a Yen2096.00 price target. To see the full list of analyst forecasts on Bando Chemical Industries Ltd. stock, see the JP:5195 Stock Forecast page.
Bando Chemical Industries reported a 1.7% increase in revenue to 59,094 million yen for the six months ending September 30, 2025, with a notable 45.7% rise in profit before tax. The company also announced an increase in dividends, reflecting strong financial performance and improved equity ratio, which may positively impact stakeholders and enhance its market position.
The most recent analyst rating on (JP:5195) stock is a Hold with a Yen2096.00 price target. To see the full list of analyst forecasts on Bando Chemical Industries Ltd. stock, see the JP:5195 Stock Forecast page.
Bando Chemical Industries, Ltd. has announced the acquisition of its own shares, acquiring 186,600 shares at a cost of 367,251,596 yen during October 2025. This move is part of a larger plan approved by the Board of Directors to acquire up to 1,800,000 shares by April 2026, reflecting the company’s strategy to manage its capital structure and potentially enhance shareholder value.
The most recent analyst rating on (JP:5195) stock is a Hold with a Yen2096.00 price target. To see the full list of analyst forecasts on Bando Chemical Industries Ltd. stock, see the JP:5195 Stock Forecast page.